T1	Intervention 36 128	chronic hepatitis B patients treated with different doses of recombinant hepatitis B vaccine
T2	Intervention 227 320	chronic hepatitis B patients treated with different doses of recombinant hepatitis B vaccine.
T3	Intervention 329 420	Seventy-two chronic hepatitis B patients who did not use any anti-HBV drugs within 6 months
